TAS-102, a novel antitumor agent: A review of the mechanism of action
- 1 November 2015
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 41 (9), 777-783
- https://doi.org/10.1016/j.ctrv.2015.06.001
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death & Disease, 2013
- UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporationNucleic Acids Research, 2011
- Effect of the Thymidylate Synthase Inhibitors on dUTP and TTP Pool Levels and the Activities of DNA Repair Glycosylases on Uracil and 5-Fluorouracil in DNABiochemistry, 2010
- Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cellsBMC Cancer, 2010
- Base Excision by Thymine DNA Glycosylase Mediates DNA-Directed Cytotoxicity of 5-FluorouracilPLoS Biology, 2009
- Participation of DNA repair in the response to 5-fluorouracilCellular and Molecular Life Sciences, 2008
- Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidineEuropean Journal of Cancer, 2007
- Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cellsBritish Journal of Cancer, 2007
- The incorporation of uracil into animal cell DNA in vitroCell, 1978
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957